Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 51-60 of 127 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisisWatkins, D.; Hughes, T.; White, D.; D'Andrea, R.
2011OCT-1 as a determinant of response to antileukemic treatmentEngler, J.; Hughes, T.; White, D.
2013Low GFI1 expression in white blood cells of CP-CML patients at diagnosis is strongly associated with subsequent blastic transformationKok, C.; Watkins, D.; Leclercq, T.; D'Andrea, R.; Hughes, T.; White, D.
2011Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trialKantarjian, H.; Hochhaus, A.; Saglio, G.; de Souza, C.; Flinn, I.; Stenke, L.; Goh, Y.; Rosti, G.; Nakamae, H.; Gallagher, N.; Hoenekopp, A.; Blakesley, R.; Larson, R.; Hughes, T.
2004Monitoring of minimal residual disease in chronic myeloid leukemiaFaderl, S.; Hochhaus, A.; Hughes, T.
2009Clinical Investigation of C-Terminal Cross-Linking Telopeptide Test in Prevention and Management of Bisphosphonate-Associated Osteonecrosis of the JawsKunchur, R.; Need, A.; Hughes, T.; Goss, A.
2008International standardisation of quantitative real-time RT-PCR for BCR-ABLCross, N.; Hughes, T.; Hochhaus, A.; Goldman, J.
2010Practical considerations for monitoring patients with chronic myeloid leukemiaBranford, S.; Hughes, T.
2003Molecular monitoring of chronic myeloid leukemiaHughes, T.; Branford, S.
2003Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitorsDewar, A.; Domaschenz, R.; Doherty, K.; Hughes, T.; Lyons, A.